AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

MBIO · NASDAQ · Biotechnology

Mustang Bio (MBIO)

Develops a combined oncolytic-virus and CAR T treatment for recurrent brain tumors.

$0.5473

At close−0.00 (−0.15%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions0 holders · as of Jun 30, 2026 · largest filers only	≥ 1.50%	113.7K shares
Insiders4 holders · as of Apr 27, 2026	0.03%	2.4K shares
Strategic holders1 holder · as of Jan 5, 2026	7.09%	537.2K shares
Otherremainder	≤ 91.38%	6.92M shares

7.58M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Fortress Biotech, Inc.Strategic10 percent owner	7.09%	537,243	13Dfiled Jan 5, 2026 ↗
Geode Capital Management, LLCInstitution	0.56%	42,240	13Fas of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution	0.42%	32,120	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	0.34%	25,704	13Fas of Jun 30, 2026
Susquehanna International Group, LLPInstitution	0.18%	13,664	13Fas of Jun 30, 2026
Manuel MD LitchmanInsiderdirector, officer: President, CEO and Interim CFO	0.02%	1,615	Form 4filed Apr 27, 2026 ↗
Adam J. ChillInsiderdirector	0.00%	375	Form 4filed Dec 30, 2025 ↗
David JinInsiderdirector	0.00%	286	Form 4filed Dec 30, 2025 ↗
Neil HerskowitzInsiderdirector	0.00%	145	Form 4filed Dec 30, 2025 ↗
Lindsay A. Md Rosenwald¹Insiderdirector	0.02%	1,211	Form 4filed Jul 7, 2023 ↗
Michael S. Weiss¹Insiderdirector	0.01%	993	Form 4filed Jul 7, 2023 ↗
Michael J. Zelefsky¹Insiderdirector	0.01%	379	Form 4filed Jul 7, 2023 ↗
Brian Achenbach²Insiderofficer: SVP, Fin. & Corp. Controller	0.00%	193	Form 4filed Dec 16, 2021 ↗
Peter Carney³Insiderofficer: See Remarks	0.00%	80	Form 4filed Dec 19, 2023 ↗
David J. Horin⁴Insiderofficer: Interim CFO	0.00%	0	Form 4filed Jun 30, 2017 ↗
Eliot M. Lurier⁵Insiderofficer: Interim CFO	0.00%	0	Form 4filed Jun 7, 2022 ↗

Last filed Jul 7, 2023; leaving the company requires no filing. Not in the bar.
Last filed Dec 16, 2021; leaving the company requires no filing. Not in the bar.
Last filed Dec 19, 2023; leaving the company requires no filing. Not in the bar.
Last filed Jun 30, 2017; leaving the company requires no filing. Not in the bar.
Last filed Jun 7, 2022; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

113.7K shares

Holder	Shares	% of company	Chg q/q	Filed
Geode Capital Management, LLC	42.2K	0.56%	−50.6K	Aug 12, 2026
Vanguard Fiduciary Trust Co	32.1K	0.42%	0	Aug 13, 2026
Vanguard Capital Management LLC	25.7K	0.34%	0	Aug 13, 2026
Susquehanna International Group, LLP	13.7K	0.18%	+13.7Knew	Aug 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Fortress Biotech, Inc.	12.40%		13D	Jan 3, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Dec 30, 2025	David Jindirector	Purchase	247	$0.9620	286
Dec 30, 2025	Adam J. Chilldirector	Sale	4	$0.9548	375
Dec 30, 2025	Neil Herskowitzdirector	Sale	247	$0.9620	145

CongressHouse and Senate disclosures

Not reported.